Announcements Trials
Browse Landscape

Phase

Phase 1 13Phase 1/2 9Phase 2 8Phase NA 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 58Breast 16Gastrointestinal 15Genitourinary 10Head & Neck 8Sarcoma 6Gynecologic 6CNS 6Dermatologic 5Endocrine 2Other solid neoplasm 1NET 1

Conditions

Neuroendocrine Tumors 18Pituitary Neoplasms 5Pheochromocytoma 3Insulinoma 3Thyroid Carcinoma, Anaplastic 2Pituitary ACTH Hypersecretion 2Paraganglioma 2Neuroblastoma 2Multiple Endocrine Neoplasia Type 1 2Meningioma 2Lung Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Carcinoid Tumor 2Breast Neoplasms 2Adrenocortical Carcinoma 2Adrenal Gland Neoplasms 2von Hippel-Lindau Disease 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Sexual Infantilism 1Serotonin Syndrome 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroma, Acoustic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lung Neoplasms × Endocrine × Clear all
NCT02817945 2022-04-07

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNETThoracic

Lung Neoplasms, Neuroendocrine Tumors

NCT01086696 2019-12-17

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
6 enrolled
BreastEndocrineGenitourinaryThoracic

Adrenal Gland Neoplasms, Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡